Tectonic Therapeutic | AVRO - Capital Social Ordinario

Precio De Mercado
32.71
Cambio Diario
-0.60 -1.80%
Mensual
55.10%
Anual
36.52%
Q1 Expectativa
32.30




Capital Social Ordinario Cambio Fecha
Akebia Therapeutics USD 2K 0 2025-03
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
Celltrion KRW 218.78M 1.5M 2025-09
Cspc Pharmaceutical CNY 11.52B 486M 2025-06
Deva Holding AS TRY 200.02M 0 2023-09
Dianthus Therapeutics USD 42.85M 42.82M 2025-09
Divis Laboratories Ltd INR 265.47M 264.53M 2025-09
Gilead Sciences USD 1.24B 1000K 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
Kangmei Pharma CNY 13.86B 0 2025-06
Karyopharm Therapeutics USD 13K 0 2024-09
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
MacroGenics USD 63.26M 62.63M 2025-09
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Organigram Holdings CAD 134.46M 438.86K 2025-09
Ovoca Bio EUR 11.06M 0 2022-06
Pfizer USD 5.69B 1000K 2025-09
Pharma Mar EUR 17.36M 214.99K 2025-12
Qiagen NV USD 216.56M 284.67K 2025-12
Roche Holding CHF 795.62M 699.54K 2025-12
Sarepta Therapeutics USD 104.96M 196K 2025-12
Sartorius EUR 69.04M 0 2025-09
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Takeda JPY 1.58B 2K 2025-12
Tilray USD 1.06B 86.93M 2025-03
Zz Pientze Pharmaceu CNY 603.32M 0 2025-09